United States · 
Who invested in 4G Clinical?
4G Clinical's investors include Schooner Capital.
United States · Series A startup
Who invested in 4G Clinical
Funding summaryUpdated 26 Oct 2026
$5.0Mraised across 1 round since 2016, from 1 source
- Latest round
- Series A, $5.0MOct 2016
- Investors
- 1
The rounds
- Oct 2016
Founders and team
From 4G Clinical's own website and the SEC filings it signed: 2 founders, 11 on the team.
David KelleherFounder, CEONamed on its 2020 Form D
Ed TourtellotteFounder, Board Director
- Anne HinkleCFO
- Rob CampanellaCTO
- Carla ReisVP, Enterprise Customer Operations
- Jenna FlowerVP, CRO and Biopharma Operations
- Kathleen GreenoughVP, Biotech Customer Operations
- Libbi RickenbacherVP, Marketing & Partnerships
- Michael MarlattVP, People
- Patrick ChokronVP, Engineering
- Loek DaamsGeneral Counsel
- Edward D. HendersonExecutive Officer, Directori
- Edward D. TourtellotteExecutive Officer, Directori
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about 4G Clinical
How much has 4G Clinical raised?
4G Clinical has raised $5.0M across 1 round since 2016.
When did 4G Clinical last raise?
4G Clinical's most recent round was a Series A of $5.0M in Oct 2016.
What was 4G Clinical's biggest round?
Its most recent round, $5.0M in Oct 2016, is also its largest on record.
Who backed 4G Clinical first?
4G Clinical's first round on record, in Oct 2016, was backed by Schooner Capital.
What stage is 4G Clinical at?
4G Clinical's latest named round is a Series A, in Oct 2016.
Where is 4G Clinical based?
4G Clinical is based in the United States.
Companies like 4G Clinical
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.